Mark Bond

4.6k total citations · 1 hit paper
61 papers, 3.8k citations indexed

About

Mark Bond is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Mark Bond has authored 61 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Cell Biology. Recurrent topics in Mark Bond's work include Protease and Inhibitor Mechanisms (11 papers), Signaling Pathways in Disease (9 papers) and Hippo pathway signaling and YAP/TAZ (7 papers). Mark Bond is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Signaling Pathways in Disease (9 papers) and Hippo pathway signaling and YAP/TAZ (7 papers). Mark Bond collaborates with scholars based in United Kingdom, United States and Taiwan. Mark Bond's co-authors include Andrew C. Newby, Andrew H. Baker, Graciela B. Sala‐Newby, Rosalind P. Fabunmi, Gillian Murphy, A.C. Newby, Nina Z. Moore, Jian Qi, Quteba Ebrahem and Bela Anand‐Apte and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Circulation Research.

In The Last Decade

Mark Bond

61 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

2003 520 citations Jian Qi, Quteba Ebrahem et al. Nature Medicine profile →

Peers

Countries citing papers authored by Mark Bond

Since Specialization

Citations

This map shows the geographic impact of Mark Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bond more than expected).

Fields of papers citing papers by Mark Bond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bond. The network helps show where Mark Bond may publish in the future.

Co-authorship network of co-authors of Mark Bond

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bond. A scholar is included among the top collaborators of Mark Bond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bond. Mark Bond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extracellular matrix stiffness controls cardiac fibroblast proliferation via the nuclear factor-Y (NF-Y) transcription factor 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Hunaid A. Vohra, Andrew C. Newby, Mark Bond	10
2	Combined role for YAP-TEAD and YAP-RUNX2 signalling in substrate-stiffness regulation of cardiac fibroblast proliferation 2022 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Graciela B. Sala‐Newby, Claire Hudson, Tomomi Kimura, (unknown), (unknown), (unknown), Rebecca J. Richardson, Andrew C. Newby, Mark Bond	27
3	Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Jason Wray, Graciela B. Sala‐Newby, Charles C.T. Hindmarch, Sarah A. Smith, (unknown), Andrew C. Newby, Mark Bond	18
4	Antiproliferative and Antimigratory Effects of a Novel YAP–TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking 2019 ·Journal of Medicinal Chemistry ·Sarah A. Smith, Richard B. Sessions, Deborah K. Shoemark, Christopher Williams, (unknown), (unknown), Matthew P. Crump, Tristan R. McKay, Gemma Harris, Andrew C. Newby, Mark Bond	64
5	Elevated cyclic-AMP represses expression of exchange protein activated by cAMP (EPAC1) by inhibiting YAP-TEAD activity and HDAC-mediated histone deacetylation 2019 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), (unknown), Sarah A. Smith, Jason Wray, K L Ford, Andrew C. Newby, Mark Bond	13
6	Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis 2018 ·EMBO Molecular Medicine ·Alexander Greenhough, (unknown), Kate J. Heesom, David Gurevich, David M. Gay, Mark Bond, T J Collard, Chris Paraskeva, Paul Martin, Owen J. Sansom, Karim Malik, Ann C. Williams	72
7	Dual Role of CREB in The Regulation of VSMC Proliferation: Mode of Activation Determines Pro- or Anti-Mitogenic Function 2018 ·Scientific Reports ·Claire Hudson, Tomomi Kimura, Aparna Duggirala, Graciela B. Sala‐Newby, Andrew C. Newby, Mark Bond	22
8	Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells 2017 ·Scientific Reports ·(unknown), Claire Hudson, Tomomi Kimura, Stephen J. White, Graciela B. Sala‐Newby, Andrew C. Newby, Mark Bond	13
9	Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer 2016 ·Value in Health ·Irina A. Tikhonova, Martin Hoyle, Tristan Snowsill, Louise Crathorne, (unknown), Jaime Peters, Simon Briscoe, Mark Bond, Nicola Huxley	1
10	cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1 2014 ·Journal of Molecular and Cellular Cardiology ·Aparna Duggirala, Tomomi Kimura, Graciela B. Sala‐Newby, Jason L. Johnson, Yih‐Jer Wu, Andrew C. Newby, Mark Bond	15
11	Proliferation unleashed: The role of Skp2 in vascular smooth muscle cell proliferation 2010 ·Frontiers in bioscience ·Mark Bond	13
12	The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model 2009 ·Health Technology Assessment ·Mark Bond, Stuart Mealing, Rob Anderson, Julian Elston, Graeme M. Weiner, RS Taylor, Martin Hoyle, (unknown), Alison Price, Ken Stein	239
13	Effectiveness of multi‐channel unilateral cochlear implants for profoundly deaf children: a systematic review 2009 ·Clinical Otolaryngology ·Mark Bond, Julian Elston, Stuart Mealing, Rob Anderson, Graeme M. Weiner, R. Taylor, (unknown), Ken Stein	28
14	Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619 2008 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Saima Muzaffar, Nilima Shukla, Mark Bond, Graciela Sala-Newby, Gianni D. Angelini, A.C. Newby, J.Y. Jeremy	29
15	Exogenous Hydrogen Sulfide Inhibits Superoxide Formation, NOX-1 Expression and Rac<sub>1</sub> Activity in Human Vascular Smooth Muscle Cells 2008 ·Journal of Vascular Research ·Saima Muzaffar, Nilima Shukla, Mark Bond, Andrew C. Newby, Gianni D. Angelini, Anna Sparatore, Piero Del Soldato, Jamie Y. Jeremy	95
16	Biphasic effect of p21Cip1 on smooth muscle cell proliferation: Role of PI 3-kinase and Skp2-mediated degradation 2005 ·Cardiovascular Research ·Mark Bond, Graciela Sala-Newby, Ying Wu, A.C. Newby	32
17	Regulation of vascular smooth muscle cell proliferation, migration and death by heparan sulfate 6‐O‐endosulfatase1 2005 ·FEBS Letters ·Graciela B. Sala‐Newby, Sarah J. George, Mark Bond, Gurtej K. Dhoot, Andrew C. Newby	18
18	Focal Adhesion Kinase (FAK)-dependent Regulation of S-phase Kinase-associated Protein-2 (Skp-2) Stability 2004 ·Journal of Biological Chemistry ·Mark Bond, Graciela B. Sala‐Newby, Andrew C. Newby	53
19	A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 breakdown → 2003 ·Nature Medicine ·Jian Qi, Quteba Ebrahem, Nina Z. Moore, Gillian Murphy, Lena Claesson‐Welsh, Mark Bond, Andrew H. Baker, Bela Anand‐Apte	520
20	Tissue Inhibitor of Metalloproteinase-3 Induces a Fas-associated Death Domain-dependent Type II Apoptotic Pathway 2002 ·Journal of Biological Chemistry ·Mark Bond, Gillian Murphy, Martin R. Bennett, Andrew C. Newby, Andrew H. Baker	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact